|Articles|February 5, 1997

FDA clears Toshibas DCA technique

Toshiba America Medical Systems of Tustin, CA, has received 510(k)clearance for its Directional Color Angio (DCA) technique forthe PowerVision ultrasound scanner (SCAN Special Report 12/96).DCA combines color ultrasound angio images with directional blood-flowinformation from conventional color Doppler, allowing cliniciansto determine tissue perfusion and differentiate between arterialand venous blood flow. DCA is a standard feature on PowerVisionscanners.

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related to this article

October 12th, 2026

Key Sessions of Interest for Radiologists at the Upcoming HLTH USA Conference

How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.

October 12th, 2026

Why Dutifully Waiting in Line is No Longer an Option for Advancement in Radiology

While the allure of partnership or a hierarchical promotion system for those who paid their dues once sounded promising, the current reality amid declining reimbursements, thinning practice margins and private equity acquisitions is going after the gig with the most optimal lifestyle and paycheck.

October 11th, 2026

Diagnostic Imaging’s Weekly Scan: October 4 — October 10

Catch up on the top radiology content of the past week.

October 9th, 2026

The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 3

In the third of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss recent developments with autonomous AI in breast imaging and share their perspective on the overall potential of AI to help mitigate the radiologist shortage.

October 9th, 2026

What New Dosimetry Data Reveals About 177Lu-Edotreotide for GEP-NET Treatment

In a recent interview, Amir Iravani, MD, FRACP, discussed the radiotherapeutic agent 177Lu-edotreotide and new dosimetry data from the COMPETE trial that was recently presented at the ASTRO conference.

October 8th, 2026

The Responsibility of Authorship in the AI Era

While AI offers the lure of efficiency and cleaner writing in scientific research, maintaining the principles of authorship and intellectual engagement is perhaps more important than ever before.

October 7th, 2026

FDA Clears AI-Powered Platform for Converting Spine MRIs to 3D Visualizations

The cloud-based NextMR platform reportedly provides automated 3D bone images of conventional spine MRI images in less than 60 seconds.

October 7th, 2026

Study Shows Impact of Key mpMRI Features for Enhancing Assessment of Renal Masses

Incorporation of pseudocapsule presence into a modified Clear Cell Likelihood Score (m-ccLS) was associated with a greater than 11 percent higher AUC in differentiating benign and malignant renal masses on mpMRI, according to a new study.

FDA clears Toshiba&#146;s DCA technique